FTRC releases results of critical illness review

With the help of a panel of medical professionals, Finance & Technology Research Centre's (FTRC) reviews critical illness wordings within its product comparison tool Quality Analyser every six months. As a result of the review, insurer scores have been adjusted in eight high incidence conditions. These include: Benign brain tumour, carcinoma in situ of the colon or rectum, carcinoma in situ of the cervix, low grade prostate cancer, cardiomyopathy, coronary angioplasty, Parkinson's disease and pulmonary hypertension. Parkinson's disease FTRC's medical panel has obtained new data reg...